Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. InfuScience, Inc. dba Bioscrip Infusion Services
WARNING LETTER
•InfuScience, Inc. dba Bioscrip Infusion Services•July 30, 2019

InfuScience, Inc. dba Bioscrip Infusion Services – FDA Warning Letter, Jul 30, 2019

Record Details

This is an amended FDA Warning Letter (WL # 285620) issued to InfuScience, Inc. dba BioScrip Infusion Services, following an inspection from July 23-30, 2019. The inspection revealed serious deficiencies in sterile drug product production, leading to adulterated drug products under FDCA Section 501(a)(2)(A).

Key violations include: 1. Personnel not disinfecting/changing gloves after high-risk activities before resuming aseptic processing. 2. Inadequate smoke studies under dynamic conditions for ISO 5 areas. 3. Facility design allowing air influx from unclassified to classified areas. 4. Failure to adequately segregate, clean, and deactivate surfaces/utensils when producing beta-lactam drugs to prevent cross-contamination. 5. Blocking first pass air in ISO 5 hoods during aseptic production. 6. Failure to disinfect materials/supplies before entering ISO 5 areas from ISO 7 areas. 7. Inconsistent disinfectant contact time and coverage. 8. Visibly dirty ISO 5 classified LAF hoods (e.g., "staining" on HEPA grates). 9. Inadequate personnel monitoring (no fingertip testing, media fill qualifications for nurses, or gown sampling).

The FDA reviewed the firm's August 19, 2019, response

Company
InfuScience, Inc. dba Bioscrip Infusion Services
Inspection date
July 30, 2019
Product type
Drugs
Office
Division of Pharmaceutical Quality Operations I
Person
  • Diana Amador-Toro (District Director)
View Company Profile

ID · 1223955e-05a5-422b-8154-7f361c9f9d2a

Violation Codes5
21 U.S.C. 351(a)(2)(B)21 U.S.C. 352(f)(1)21.U.S.C. 355(a)21 U.S.C. 331(k)FD&C Act 501(a)(2)(A)

Full citation text and observation details available on the Dashboard.

Other documents for InfuScience, Inc. dba Bioscrip Infusion Services
  • 483 - 2021-10-08October 8, 2021
  • 483 - 2019-07-30July 30, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore InfuScience, Inc. dba Bioscrip Infusion Services
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.